中药在糖尿病心肌病动物模型中的疗效:系统综述与Meta分析
该系统综述与Meta分析检索Web of Science、PubMed、Cochrane Library与CNKI,纳入2013年至2023年4月24日间24项在糖尿病心肌病动物模型中评价中药疗效的研究,共涉及24种中药干预与2157只动物。汇总数据显示,中药干预可显著改善体重、心重/体重比、甘油三酯与胆固醇水平、射血分数、缩短分数及E/A比值;亚组分析与Meta回归提示中药种类、干预时长、造模方法与动物种属是异质性的潜在来源。
要点
- 中药干预可改善DCM动物模型的体重、心重/体重比及血脂水平。
- 中药干预与射血分数、缩短分数、E/A比值等心功能指标改善相关。
- 中药种类、干预时长、造模方法与动物种属可能是异质性来源。
核心结论
- 中药干预与糖尿病心肌病动物模型体重、心重/体重比、甘油三酯和胆固醇水平、收缩期左心室内径、射血分数、缩短分数及E/A比值的显著改善相关。
- 亚组分析与Meta回归提示中药种类、干预时长、造模方法和动物种属是结果异质性的潜在来源。
研究设计与样本
- 系统综述与Meta分析,检索Web of Science、PubMed、Cochrane Library和CNKI,纳入2013年至2023年4月24日的文献。
- 共纳入24项研究,涉及24种中药干预和2157只动物。
- 系统综述注册号为CRD42023402908。
主要发现
- 汇总数据显示,中药干预使体重、心重/体重比、甘油三酯和胆固醇水平、射血分数、缩短分数及E/A比值出现显著改善。
- 亚组分析和Meta回归发现,中药种类、干预时长、造模方法与动物种属是异质性的潜在来源。
关键数值与推荐
- 纳入标准为报告中药对糖尿病心肌病动物模型疗效的研究。
- 检索时间限定为2013年至2023年4月24日。
- 共24种中药干预、2157只动物符合纳入标准。
临床怎么用
- 该证据来自动物模型,提示中药对糖尿病心肌病多项代谢与心功能指标可能有益,尚不能直接推及临床用药决策。
- 临床解读时应关注中药种类、干预时长、造模方法与动物种属对疗效估计的影响。
局限性
- 证据仅来自动物模型研究,不能直接外推至患者人群。
- 结果存在异质性,其潜在来源包括中药种类、干预时长、造模方法和动物种属。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Diabetic cardiomyopathy (DCM) is a severe complication of diabetes that can diminish the quality of life in patients and is a leading cause of death. Research has demonstrated the effectiveness of Traditional Chinese Medicine (TCM) in reducing blood sugar levels and protecting cardiovascular function in both animal models and clinical research studies. Nevertheless, the efficacy of TCM in animal models of DCM has not been analyzed systematically. Method: We searched the following electronic bibliographic databases: Web of Science, PubMed, Cochrane Library, and CNKI(China National Knowledge Infrastructure). Studies that reported the efficacy of TCM in animals with DCM were included. The literature search was conducted using the terms. The data will be restricted from the year 2013 to 24 April 2023, 24 studies were included in the meta-analysis. Result: A total of 24 Traditional Chinese Medicine interventions and 2157 animals met the inclusion criteria. The pooled data revealed that TCM interventions resulted in significant improvements in body weight (BW), heart weight (HW) to body weight ratio (HW/BW), triglyceride (TG) and cholesterol (TC) levels, ejection fraction (EF), fractional shortening (FS) and E/A ratio. Subgroup analysis and meta-regression revealed that the type of TCM, duration of intervention, method of modeling, and animal species were potential sources of heterogeneity. Conclusion: TCM interventions were associated with significant improvements in body weight, heart weight to body weight ratio, triglyceride and cholesterol levels, left ventricular internal dimension in systole, ejection fraction, fractional shortening and E/A ratio. The heterogeneity in the results was found to be potentially due to the type of TCM, duration of intervention, method of modeling, and animal species, as shown in subgroup analysis and meta-regression. Systematic Review Registration: identifier CRD42023402908.
引用
- Hu L, Qian L, Sun A, et al. Efficacy of traditional Chinese medicine on diabetic cardiomyopathy in animal models: a systematic review and meta-analysis. Front Pharmacol. 2023. PMID: 37849730. doi:10.3389/fphar.2023.1253572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。